DetailDesc: CAL-101 (Idelalisib, GS-1101) is a selective p110δ inhibitor with IC50 of 2.5 nM; shown to have 40- to 300-fold greater selectivity for p110δ thanp110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR We can provide a Certificate of Analysis and proton NMR spec...

DetailDesc: Superiority COMPANY VALUE: 1. We are committed to protect the integrity of our products and services. 2. Our Research and Development professional team is consisted of PhDs and Masters in biochemistry and pharmacy. 3. Our Production facility is operated by the seasoned staffs wi...

DetailDesc: Idelalisib (GS-1101 or CAL-101) is a drug used for the treatment of chronic lymphocytic leukemia. The substance acts as a phosphoinositide 3-kinase inhibitor; more specifically, it blocks P110 δ , the delta isoform of the enzyme phosphoinositide 3-kinase .